Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'tranylcypromine 2 pcpa hcl'

Search results for: 'tranylcypromine 2 pcpa hcl'

Items 11-20 of 46

Page
per page
  1. WZ8040
    A1393 WZ8040
    Target: EGFR
    Summary: EGFR T790M inhibitor,irreversible amd potent
      ≥24.05 mg/mL
  2. EGF816
    B5889 EGF816
     2 Citation
    Target: EGFR
    Summary: Novel covalent inhibitor of mutant-selective EGFR
      Soluble in DMSO
  3. MLR 1023
    B5648 MLR 1023
    Target: Lyn kinase
    Summary: allosteric activator of Lyn kinase
  4. H-7 dihydrochloride
    B6342 H-7 dihydrochloride
    Target: PKC|PKG|PKA|Myosin light chain kinases (MLCKs)
    Summary: protein kinase inhibitor
      Soluble in DMSO
  5. MGCD-265
    A5057 MGCD-265
    Target: VEGFR|c-MET
    Summary: Met/Flt/Flk/Ron/Tie-2 inhibitor
      ≥25.9 mg/mL
  6. Ki8751
    A1821 Ki8751
    Target: VEGFR
    Summary: VEGFR-2 inhibitor,potent and selective
      ≥23.45 mg/mL
  7. Motesanib
    A3632 Motesanib
    Target: VEGFR
    Summary: Inhibitor of Flk-1/Flt-4/PDGFR-/c-Kit
      ≥42 mg/mL
  8. Altiratinib
    B5832 Altiratinib
     1 Citation
    Target: FLT3|VEGFR|Trk Receptors|c-MET|Tie-2
    Summary: c-MET/TIE-2/VEGFR inhibitor
      ≥21.55 mg/mL
  9. Ki20227
    A3527 Ki20227
    Target: c-Fms tyrosine kinase
    Summary: C-Fms tyrosine kinase inhibitor
      ≥48.1 mg/mL
  10. Tie2 kinase inhibitor
    A5979 Tie2 kinase inhibitor
    Target: Tie-2
    Summary: Tie-2(Tie2 ) inhibitor
      ≥22 mg/mL

Items 11-20 of 46

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 1 item
  2. Axl 1 item
  3. ALK 1 item
  4. Broad Spectrum Protein Kinase Inhibitor 1 item
  5. c-FMS 1 item
  6. c-Kit 1 item
  7. c-MET 5item
  8. c-RET 1 item
  9. CSF-1R 1 item
  10. EGFR 8item
  11. FAK 3item
  12. FGFR 4item
  13. HER2 3item
  14. LRRK2 3item
  15. PDGFR 6item
  16. Pyk2 2item
  17. Spleen Tyrosine Kinase (Syk) 2item
  18. Src 2item
  19. Tie-2 2item
  20. Trk 1 item
  21. VEGFR 11item
Reversibility
  1. Reversible 5item
  2. Irreversible 2item
Target
  1. Raf 3item
  2. CSF-1R 1 item
  3. FLT3 3item
  4. Eph Receptors 1 item
  5. VEGFR 16item
  6. PDGFR 6item
  7. c-Kit 4item
  8. RET 2item
  9. Bcr-Abl 1 item
  10. FGFR 4item
  11. MET 4item
  12. Src 1 item
  13. Trk Receptors 2item
  14. EGFR 7item
  15. FAK 3item
  16. BMP and Other Activin Receptors 1 item
  17. Syk 2item
  18. ErbB 2item
  19. c-MET 2item
  20. PKC 1 item
  21. Pyk2 3item
  22. LRRK2 3item
  23. PKG 1 item
  24. PKA 1 item
  25. Myosin light chain kinases (MLCKs) 1 item
  26. Tie-2 2item
  27. Flk-1 1 item
  28. c-Fms tyrosine kinase 1 item
  29. Lyn kinase 1 item
  30. DCLK2 1 item
Reported Experiments
  1. Animal Experiments 43item
  2. Cell Experiments 28item
Related Disease
  1. Acute Myeloid Leukemia 2item
  2. Adrenocortical Carcinoma 1 item
  3. Advanced Renal Cell Carcinoma 1 item
  4. Bladder Cancer 3item
  5. Bladder Carcinoma 1 item
  6. Breast Cancer 10item
  7. Cancer 34item
  8. Cholangiocarcinoma 1 item
  9. Chronic Lymphocytic Leukemia 1 item
  10. Clear Cell Renal Cell Carcinoma 1 item
  11. Colon Cancer 2item
  12. Colon Carcinoma 1 item
  13. Colorectal Cancer 7item
  14. Glioblastoma 3item
  15. Glioma 2item
  16. Hepatocellular Carcinoma 2item
  17. Liver Cancer 2item
  18. Lung Cancer 3item
  19. Lung Carcinoma 1 item
  20. Lymphoma 1 item
  21. Melanoma 2item
  22. Multiple Myeloma 3item
  23. Non-small Cell Lung Cancer 3item
  24. Ovarian Cancer 2item
  25. Pancreatic Cancer 7item
  26. Prostate Cancer 3item
  27. Renal Cancer 1 item
  28. Renal Cell Carcinoma 3item
  29. Thyroid Cancer 3item